The novel HIF-1α inhibitor, 2-methoxyestradiol (2-ME) could efficiently inhibit radiation-induced lung fibrosis in a preclinical study (Nam et al., 2021). This evidence concerns the gene HIF1A and pulmonary fibrosis.